"our test may offer a substantial improvement over existing ovarian cancer blood tests"
This is old methods being refined not new tech and this isn't something that will be able to be sold at a chemist like a pregnancy test. It would be hard to widely sell a blood test that is 10% of the time wrong and would likely need to be improved with new evidence in another clinical trial. Its probably already gone as far as it deserves but hype train will probably keep pushing.
Ann: OVARIAN CANCER CLINICAL STUDY RESULTS, page-16
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.015(2.65%) |
Mkt cap ! $63.96M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 58.0¢ | 56.0¢ | $38.51K | 68.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2293 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 13111 | 1 |
View Market Depth
| Last trade - 15.48pm 12/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |